15 Aug 2018 16:10
UK Shareholder Meetings Calendar - Next 7 Days
Thursday 16 Augustno events scheduledFriday 17 AugustMX 20 21 Natural Focus (re sale
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
COS.L Share News (COS)
COS Share
Price
COS Share
News
COS Share
Chat
COS Share
Trades
COS
Live RNS
COS Share
Charts
COS Broker
Ratings
COS Directors
Deals
COS Financial
Diary
COS
Fundamentals
COS Short
Positions
COS
Media
COS.L Information
- There is currently no data for COS
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Collagen Solutions's losses narrow on improved top line performance
Tue, 09th Apr 2019 08:08
(Sharecast News) - Biomaterials and regenerative medicines outfit Collagen Solutions expects to report narrowed pre-tax losses for the year ended 31 March, thanks to an improvement in revenues.Collagen anticipates revenues for the full year will come to £4.15m, ahead of market expectations and the previous year's £3.5m figure by 18%.The AIM-listed outfit said revenues from agreements to develop collagen products on behalf of third parties continued to "contribute significantly" to the business in the second half and will make up approximately 33% of its revenue for the year.Management also expected the sale of its holding in Jellagen to help it reduce its red ink.Trading had been in line with expectations since year-end, with the company continuing to build on the progress seen in its last trading year, supported by the new business gained in the second half of the last financial year and new deals.Chief executive Jamal Rushdy said: "We are pleased with our delivery of high double-digit growth within our core business representing a substantial turn-around of performance from our prior financial year."In addition, our increased mix of development services is a positive leading indicator of success in our strategy to move up the value chain. We look forward to providing a further update when we announce our preliminary results in July."As of 1150 BST, Collagen Solutions shares had dipped 1.47% to 3.35p.
More News
4 Apr 2018 11:30
Collagen Solutions To Record Widened Annual Loss On Contract Delays
LONDON (Alliance News) - Shares in Collagen Solutions PLC fell Wednesday, after the company warned that it will record a widened loss and lower revenue for the 2018 financial
Read more28 Mar 2018 11:13
Collagen To Restructure New Zealand Unit, Expects Annual Loss to Widen
LONDON (Alliance News) - Collagen Solutions PLC said Wednesday that it intends to re-structure its New Zealand operations for it to focus its activities a
Read more14 Feb 2017 12:02
Collagen Solutions announces capital hike
(ShareCast News) - Collagen Solutions announces a placing and open offer to raise up to £8.0m, and a conditional commitment from Norgine Ventures to subscribe for £4.0m in secured private bonds with warrants. AIM-quoted Collagen said the placing and open offer were subject to shareholder approval.
Read more19 Jan 2017 09:37
Collagen Solutions assembles scientific advisory board
(ShareCast News) - Developer and manufacturer of medical grade collagen components, Collagen Solutions, announced the creation of a new scientific advisory board on Thursday, that will advise the company on opportunities in regenerative medicine. The AIM-traded company said the three appointees are
Read more13 Jan 2017 12:13
Collagen Solutions awarded another Ph.D. studentship
(ShareCast News) - Developer and manufacturer of medical grade collagen components Collagen Solutions announced on Friday that it has been awarded a third Medical Research Scotland Ph.D. studentship, this time in partnership with Professor Elizabeth Tanner, of the School of Engineering, at the Unive
Read more19 Dec 2016 08:43
Collagen Solutions pins hopes on ChrondoMimetic as losses widen
(ShareCast News) - Medical grade collagen component developer and manufacturer Collagen Solutions posted its results for the six months to 30 September on Monday, with revenue and other income increasing by 30% to £1.89m. The AIM-traded company's adjusted LBITDA was £0.42m, widening from the £0.79m
Read more17 Aug 2016 15:04
12 Jul 2016 16:19
11 Jul 2016 11:03
Director dealings: Collagen chairman puts more skin in game
(ShareCast News) - Collagen Solutions chairman David Evans put more skin in the game on Monday as the company revealed annual losses had tightened up thanks to a plumped-up top line. Serial entrepreneur and small company backer Evans took his stake in the company up to 8.6% by snapping up 900,000
Read more